Phase 1 study to evaluate safety and preliminary efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in patients with locally advanced (LA) unresectable pancreatic ductal adenocarcinoma (PDAC)

被引:0
|
作者
Abi-Jaoudeh, Nadine
Valerin, Jennifer Brooke
Imagawa, David K.
Preise, Dina
Sacks, Zachary
Cohen, Yaniv
Rothman, Julia
Brook, Keren
Morag, Eyal
Scherz, Avigdor Joshua
Krasnopolskaya, Inna
Alpert, Genia
Chung, Vincent
Melstrom, Laleh Golkar
Kessler, Jonathan
机构
[1] Univ Calif Irvine, Div Vasc & Intervent Radiol, Dept Radiol Sci, Orange, CA USA
[2] Univ Calif Irvine, Irvine, CA USA
[3] Univ Calif Irvine, Irvine, CA USA
[4] Impact Biotech, Ness Ziona, Israel
[5] Steba Impact Biotech, Ness Ziona, Israel
[6] Weizmann Inst Sci, Dept Plants & Environm Sci, Rehovot, Israel
[7] City Hope Natl Med Ctr, Duarte, CA USA
[8] City Hope Natl Med Ctr, Med Ctr, Duarte, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS4204
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A phase 3 multicenter study to evaluate the safety and efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in treatment of low-grade (LG) upper tract urothelial cancer (UTUC).
    Coleman, Jonathan
    Margulis, Vitaly
    Scherz, Avigdor Joshua
    Krasnopolskaya, Inna
    Alpert, Genia
    Jobert, Veronique
    Preise, Dina
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Safety and efficacy of chemotherapy in older adults with locally advanced and metastatic pancreatic ductal adenocarcinoma (PDAC)
    Ostios-Garcia, Lorena
    Saade, Patricia
    Grossman, Joseph Elan
    Lanniello, Leanne
    Bullock, Andrea J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [3] EFFICACY AND SAFETY OF PADELIPORFIN VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR TREATMENT OF LOW-GRADE UPPER TRACT UROTHELIAL CANCER (LG UTUC): PHASE 3 PRELIMINARY RESULTS
    Coleman, Jonathan
    Shore, Neal
    Marcq, Gautier
    Colombel, Marc
    Psutka, Sarah
    Raman, Jay
    Margulis, Vitaly
    Singla, Nirmish
    Djaladat, Hooman
    Aigner, Reinhard
    Raventos Busquets, Carles Xavier
    Amato, Gianni
    Cohen, Yaniv
    Mroz, Axelle
    Koudinova, Natalia
    Krasnopolskaya, Inna
    Alpert, Genia
    Scherz, Avigdor
    Kaufman, Ronald
    JOURNAL OF UROLOGY, 2024, 211 (05): : E446 - E447
  • [4] ENLIGHTED phase 3 study: Efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) for treatment of low-grade upper tract urothelial cancer (LG UTUC)
    Margulis, Vitaly
    Kaufman, Ronald P., Jr.
    Marcq, Gautier
    Shore, Neal D.
    Colombel, Marc
    Uchio, Edward M.
    Psutka, Sarah P.
    Aller, Marcos
    Rausch, Steffen
    Raventos, Carles
    Shvero, Asaf
    Mroz, Axelle
    Kudinova, Natalia
    Cohen, Yaniv
    Krasnopolskaya, Inna
    Alpert, Genia
    Scherz, Avigdor Joshua
    Coleman, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] EFFICACY AND SAFETY OF PADELIPORFIN VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR TREATMENT OF LOW-GRADE UPPER TRACT UROTHELIAL CANCER (LG UTUC): ENLIGHTED PHASE 3 STUDY
    Vitaly, Margulis
    Gautier, Kaufman Jr Ronald P. Marcq
    Neal, Shore
    Asaf, Shvero
    Sarah, Psutka
    Edward, Edward Uchio
    Hooman, Djaladat
    Jay, Raman
    Marc, Colombel
    Marcos, Aller
    Steffen, Rausch
    Aigner, Reinhard
    Alexey, Medvedchikov
    Axelle, Mroz
    Natalia, Kudinova
    Yaniv, Cohen
    Jerry, Buentello
    Inna, Krasnopolskaya
    Genia, Alpert
    Avigdor, Scherz
    Jonathan, Coleman
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 97 - 98
  • [6] The Phase 1 Study of Concurrent Chemoradiation Therapy With Gemcitabine and Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Adenocarcinoma Patients
    Ioka, T.
    Katayama, K.
    Takada, R.
    Fukutake, N.
    Ohkawa, K.
    Akita, H.
    Takahashi, H.
    Konishi, K.
    Teshima, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S205 - S205
  • [7] A phase 1/2 study of combination therapy of ivaltinostat, gemcitabine, and erlotinib in patients with unresectable, locally advanced and metastatic pancreatic adenocarcinoma
    Jo, J.
    Lee, H.
    Park, S.
    Chung, D.
    Cho, S.
    Cha, H.
    Cho, J.
    Song, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S211 - S211
  • [8] Efficacy and safety of KN046 plus nab-paclitaxel/gemcitabine as first-line treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
    Jin, Gang
    Guo, Shiwei
    Zhang, Yanqiao
    Ma, Yue
    Guo, Xiaodong
    Zhou, Xiaocui
    Yu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] A phase II study of KN046 monotherapy as 2nd line and above treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
    Gang, Jin
    Guo, Shiwei
    Zhang, Yanqiao
    Ma, Yue
    Guo, Xiaodong
    Zhou, Xiaocui
    Yu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16305 - E16305
  • [10] A phase II, multi-center, open-label study to evaluate the safety and efficacy of YH003 in combination with toripalimab (anti-PD-1 mAb) in patients with unresectable/metastatic pancreatic ductal adenocarcinoma (PDAC).
    Liu, Dan
    Shen, Lin
    Ananda, Sumitra
    Cao, Dan
    Han, Catherine HyeWon
    Coward, Jermaine
    Chao, Yee
    Li, Wei
    Dass, Prashanth Hari
    Hsu, Chih-Hung
    Nagrial, Adnan
    Huang, Yuan
    Ganju, Vinod
    Chen, Xiaobing
    Cohen, Deirdre J.
    Kumar, Rajiv
    Bai, Li-Yuan
    Yuan, Ying
    Chiu, Tai-Jan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)